Comparison of Long-term Outcomes of Infliximab versus Adalimumab in 1,488 Biologic-Naive Korean Patients with Crohn’s Disease

Background/Aims: Data on the comparative effectiveness of infliximab (IFX) or adalimumab (ADA) in patients with Crohn’s disease (CD) are rare, particularly for Asian patients. We compared the key clinical outcomes (surgery, hospitalization, and corticosteroid use) of use of these two drugs in biolog...

Full description

Bibliographic Details
Published in:Gut and Liver
Main Authors: Yoon Suk Jung, Minkyung Han, Sohee Park, Jae Hee Cheon
Format: Article
Language:English
Published: Gastroenterology Council for Gut and Liver 2021-01-01
Subjects:
crohn disease
infliximab
adalimumab
Online Access:http://gutnliver.org/journal/view.html?doi=10.5009/gnl19377

Internet

http://gutnliver.org/journal/view.html?doi=10.5009/gnl19377

Similar Items